Primary Site >> Esophagus Cancer

Gene >> BID

  • 1993
  • 1995
  • 2014
  • 2015
  • 2018
Ref: [Study on clinical application of multiple fractions per day radiation therapy with concomitant boost technique for esophageal cancer].
PMID: 8340051
Ref: Treating esophageal cancer with a combination of chemotherapy, radiation, and excision.
PMID: 7747839
Ref: Phase II trial of chemotherapy, external and intraluminal radiation plus surgery for oesophageal cancer.
PMID: 8535661
Ref: Matrine inhibits proliferation and induces apoptosis via BID-mediated mitochondrial pathway in esophageal cancer cells.
PMID: 24510386
Ref: Phase I and pharmacokinetics/pharmacodynamics study of the MEK inhibitor RO4987655 in Japanese patients with advanced solid tumors.
PMID: 25809858
Ref: Potent hydrazone derivatives targeting esophageal cancer cells.
PMID: 29475156